Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
DOI

10.1016/s0140-6736(15)60432-9

Type

Journal article

Journal

Lancet (london, england)

Publication Date

02/2015

Volume

385

Addresses

Clinical Trial Service Unit, and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK; Oxford Kidney Unit, Oxford University Hospitals NHS Trust, Oxford, UK. Electronic address: richard.haynes@ctsu.ox.ac.uk.

Keywords

Humans, Recombinant Fusion Proteins, Immunosuppressive Agents, Antibodies, Monoclonal, Kidney Transplantation, Graft Rejection, Female, Male, Antibodies, Monoclonal, Humanized